Bio Protocol vs QuarkChain — how do they compare? Bio Protocol trades at Rp510.87 (market cap Rp1,15T, Rp263,61M 24h volume), while QuarkChain trades at Rp34.61 (market cap Rp251,01M, Rp8,51M 24h volume). The key difference: Bio Protocol is far larger — about 4581.5× QuarkChain's market cap, and Bio Protocol's supply is capped (2,2B / 3,3B BIO (68%)) while QuarkChain's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and QuarkChain for 31 Days on average.
| BIO | QKC | |
|---|---|---|
Market Cap | Rp1,15T | Rp251,01M |
Volume (24h) | Rp263,61M | Rp8,51M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 7,3B QKC |
Typical Hold Time | 16 Days | 31 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
QuarkChain (QKC) is trading at Rp34.98 with a market cap of Rp252.58M, showing bearish technical signals with moving averages indicating selling pressure while oscillators remain neutral. The token currently trades near support levels S1 (Rp35) and S2 (Rp34), with key resistance at R1 (Rp38). No major protocol updates or ecosystem developments have been reported recently.
Overall outlook remains cautious with technical indicators favoring bearish momentum. Key opportunities include potential bounce from support levels, while major risks include low liquidity and limited market depth. Investors should monitor for any network updates or exchange listing developments that could impact price action.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →The QuarkChain Network is a permissionless blockchain architecture that aims to meet global commercial standards. It aims to provide a secure, decentralized, and scalable blockchain solution to deliver 100,000+ on-chain TPS.
Read more on QKC →